BRIDGING COMMUNITY: Collaborative Efforts in Early Detection and Intervention for Alzheimer’s Disease

Pre-Assessment

Please enable JavaScript in your browser to complete this form.
Name
1. A 68-year-old patient with a family history of dementia is concerned about future cognitive decline. Which of the following is a recommended modifiable risk factor that you should discuss with your patient?
2. Which of the following is true concerning the relationship between perimenopause and Alzheimer’s disease?
3. What was the primary outcome that demonstrated the efficacy of amyloid-targeting therapies in patients with Alzheimer's disease?
4. What are the common symptoms associated with ARIA in patients receiving anti-amyloid therapies?
5. During a follow-up visit, a 72-year-old patient receiving anti-amyloid therapy for Alzheimer’s disease is found to have mild ARIA on imaging but reports no significant symptoms. Based on the information provided, what would you do next?
6. A 70-year-old patient with mild cognitive impairment is hopeful about trying amyloid-targeting therapy after hearing about its benefits. Her son (and caregiver) is concerned about expectations and asks, “What will this treatment do for my mom?” What would be the logical response given this scenario?
7. How confident are you in your ability to treat and manage patients with Alzheimer’s disease?
Scroll to Top